• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,4-双(氨基链烷酰胺基)-9,10-蒽二酮的合成与抗肿瘤活性评价

Synthesis and antineoplastic evaluation of 1,4-bis(aminoalkanamido)-9,10-anthracenediones.

作者信息

Martelli S, Dzieduszycka M, Stefanska B, Bontemps-Gracz M, Borowski E

机构信息

Department of Chemical Sciences, University of Camerino, Italy.

出版信息

J Med Chem. 1988 Oct;31(10):1956-9. doi: 10.1021/jm00118a015.

DOI:10.1021/jm00118a015
PMID:3172129
Abstract

The effect of the replacement of amino groups, attached to the anthraquinone ring in [(aminoalkyl)amino]-anthraquinones, by an amido function on DNA binding, cytotoxicity, and antileukemic activity has been studied. The corresponding 1,4-bis(aminoalkanamido)-9,10-anthracenediones have been synthesized and examined. It has been concluded that such modification does not exclude the DNA binding and cytotoxicity of mentioned compounds but decreases or abolishes the in vivo antileukemic activity.

摘要

研究了在[(氨基烷基)氨基]-蒽醌中连接在蒽醌环上的氨基被酰胺官能团取代对DNA结合、细胞毒性和抗白血病活性的影响。已合成并检测了相应的1,4-双(氨基烷酰胺基)-9,10-蒽二酮。得出的结论是,这种修饰并不排除上述化合物的DNA结合和细胞毒性,但会降低或消除其体内抗白血病活性。

相似文献

1
Synthesis and antineoplastic evaluation of 1,4-bis(aminoalkanamido)-9,10-anthracenediones.1,4-双(氨基链烷酰胺基)-9,10-蒽二酮的合成与抗肿瘤活性评价
J Med Chem. 1988 Oct;31(10):1956-9. doi: 10.1021/jm00118a015.
2
6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.6-[(氨基烷基)氨基]取代的7H-苯并[e]嘧啶-7-酮作为新型抗肿瘤药物。合成与生物学评价。
J Med Chem. 1993 Jan 8;36(1):38-41. doi: 10.1021/jm00053a005.
3
Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.蒽醌类化合物的构效关系研究:1,4 - 二羟基 - 5,8 - 双[[2 - (2 - 羟基乙氧基)乙基]氨基] - 9,10 - 蒽二酮,一种已确立的抗肿瘤药物的类似物。
J Pharm Sci. 1982 Jun;71(6):708-9. doi: 10.1002/jps.2600710626.
4
6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.6,9-双[(氨基烷基)氨基]苯并[g]异喹啉-5,10-二酮。一类新型的发色团修饰的抗肿瘤蒽-9,10-二酮:合成与抗肿瘤评价。
J Med Chem. 1994 Mar 18;37(6):828-37. doi: 10.1021/jm00032a018.
5
Synthesis, peroxidating ability, and antineoplastic evaluation of 1-[(aminoalkyl)amino]-4-hydroxy-10-imino-9-anthracenones.1-[(氨基烷基)氨基]-4-羟基-10-亚氨基-9-蒽酮的合成、过氧化能力及抗肿瘤评估
J Med Chem. 1991 Feb;34(2):541-6. doi: 10.1021/jm00106a009.
6
2-(1 -hydroxyiminoalkyl)-1 ,4-dimethoxy-9,10-anthraquinones: synthesis and evaluation of cytotoxicity.2-(1-羟基亚氨基烷基)-1,4-二甲氧基-9,10-蒽醌:合成及细胞毒性评估
Arch Pharm Res. 2000 Aug;23(4):283-7. doi: 10.1007/BF02975436.
7
Preparation and evaluation of 2-substituted anthraquinones based on the anthracyclines.基于蒽环类药物的2-取代蒽醌的制备与评价
J Med Chem. 1982 Apr;25(4):369-73. doi: 10.1021/jm00346a008.
8
Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.作为潜在抗肿瘤药物的9,10-蒽醌单烷基氨基烷基腙的合成
Farmaco. 1993 Dec;48(12):1641-8.
9
[Formulation and antileukemic activity of quinolizidinylalkylaminic derivatives of naphthoquinone and anthraquinone].[萘醌和蒽醌喹诺里西啶基烷基胺衍生物的制剂及其抗白血病活性]
Boll Chim Farm. 1989 Jun;128(6):208-11.
10
Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones.
J Med Chem. 1987 Sep;30(9):1682-6. doi: 10.1021/jm00392a028.

引用本文的文献

1
A highly facile approach to the synthesis of novel 2-(3-benzyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-N-phenylacetamides.一种合成新型2-(3-苄基-2,4-二氧代-1,2,3,4-四氢嘧啶-1-基)-N-苯基乙酰胺的极为简便的方法。
Tetrahedron Lett. 2013 Feb 6;54(6):576-578. doi: 10.1016/j.tetlet.2012.11.090. Epub 2012 Nov 29.
2
Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.将细胞毒性蒽醌类脂肪族氮氧化物用作前药DNA结合剂的原理:一类新型生物还原剂。
Cancer Metastasis Rev. 1993 Jun;12(2):119-34. doi: 10.1007/BF00689805.